By Kevin Ferrara, CEO, AFSO21 LLC
Introduction: The Unseen Threat of ‘Forever Chemicals’
The stark reality of life and mortality often hits us when we least expect it, or perhaps, when confronted with a public figure’s personal struggle. It was precisely this collision of celebrity and sobering diagnosis that seized my attention and set my mind spinning. The catalyst was a profoundly moving video featuring the actor Eric Dane. The video wasn’t a clip from a blockbuster or a promotional interview; instead, it was a raw, deeply personal confession, Dane speaking openly about his diagnosis with Amyotrophic Lateral Sclerosis, or ALS.
Seeing a man who has played so many roles, a doctor, a hero, a romantic lead, grappling with such an unforgiving, debilitating disease was arresting. But what resonated most profoundly wasn’t just the fact of his illness; it was the content of his message. The video captured his final words, a prepared message meant specifically for his children, a legacy of love and guidance recorded for a time when his voice would be silenced and his presence gone.
Witnessing that vulnerability, that deliberate act of parental farewell, was emotionally overwhelming. It wasn’t merely a performance; it was a deeply human moment of a father acknowledging his future absence and striving to distill a lifetime of wisdom into a few precious minutes. That video, Eric Dane’s diagnosis, his imminent mortality, and his heartfelt final address to his children, didn’t just make me pause; it fundamentally altered the rhythm of my thoughts and forced me to confront the ephemeral nature of our own existence and what we choose to leave behind.
Contemplating Dane’s experience, the underlying causes of his debilitating medical condition became a concern. I thought, what environmental factors might have contributed to the impact on his previously robust physique? A potential connection subsequently arose: could there be a correlation between the pervasive Per- and Polyfluoroalkyl Substances, or PFAS, commonly referred to as “forever chemicals,” that so many veterans, firefighters, and the general population have been exposed to, and the devastating, progressive neurodegenerative disorder known as ALS? The following is intended not as an alarmist proclamation, but rather as an examination of a concerning intersection between environmental contamination and human health.
I do not claim to be a scientist, and I assume the majority of those reading this article share this characteristic. Instead, I wish to deconstruct the complex scientific concepts into an accessible format and examine the discourse surrounding this developing field of research. My objective is not to deliver a dry academia styled presentation, but rather an expansive, yet informal and engaging, inquiry. My aim is to facilitate an understanding of not merely whether a correlation exists between PFAS and ALS, but the underlying scientific rationale for this inquiry, the current state of the evidence, and the implications for public health.
Part I: Understanding the Players
So, let’s set the stage. When I talk about PFAS, I’m talking about a group of over 12,000 synthetic chemical compounds. They’ve been around since the 1940s, and they are essentially the superheroes of chemistry when it comes to repelling water, grease, and stains. That’s why they were, and in many cases still are, in everything like non-stick cookware, stain-resistant fabrics and carpets, waterproof clothing, food packaging, and, critically, in certain firefighting turnout gear and firefighting foams used to battle petroleum fires, particularly at military bases and airports.
The problem, as you may have heard or read, is the carbon-fluorine bond PFAS possesses. It is one of the strongest chemical bonds in organic chemistry. It makes these chemicals incredibly persistent, hence the nickname “forever chemicals.” PFAS compounds don’t break down naturally in the environment or in the human body. They accumulate. They bioaccumulate up the food chain, and through scientific research, we know they certainly build up in us with every new exposure. For me personally, I have significant levels of various PFAS compounds in my body that have been there for more than 30-plus years and will likely remain when I die. PFAS compounds are everywhere, in our soil, our water, the air, and, yes, to some level, inside the bodies of nearly every person on the planet.
Now, let’s pivot to ALS. Often referred to as Lou Gehrig’s disease, ALS is a brutal illness. It’s characterized by the progressive degeneration of motor neurons, the nerve cells in the brain and spinal cord that control voluntary muscle movement. As these motor neurons die, the brain can no longer initiate and control muscle movement. People with ALS lose the ability to speak, eat, move, and eventually, breathe. The average life expectancy after diagnosis is tragically short, typically two to five years. The vast majority of ALS cases, about 90%, are classified as sporadic, meaning they occur in individuals with no known family history of the disease. This is the key point for our discussion today. Since genetics only account for a small fraction of cases, researchers have long suspected that environmental factors play a significant, perhaps even a dominant, role in triggering sporadic ALS.
Part II: Weaving the Threads of Contamination and Disease
This is where the two threads, the pervasive environmental contaminants of PFAS and the devastating, sporadic nature of ALS, begin to weave together.
Why now, why would scientists suspect PFAS, specifically, in ALS?
Well, the hypothesis isn’t pulled out of thin air. It stems from observing specific populations and understanding the mechanism of action of neurotoxins.
First, let’s look at what we already know about chemical neurotoxicity and ALS. There are established occupational and environmental risk factors for ALS. For instance, studies have suggested that veterans, especially those deployed during certain conflicts, have a higher rate of ALS. Exposure to pesticides, heavy metals, and certain industrial solvents have also been investigated as potential triggers. The common thread among many of these suspected toxins is their ability to induce oxidative stress and inflammation in the central nervous system, the very processes thought to be central to the pathology of ALS.
PFAS compounds are known to be endocrine disruptors and immunotoxicants. They can interfere with hormone signaling, affect liver function, and suppress the immune system. But, more recently, research has started to focus on their neurotoxic potential. Studies have shown that certain PFAS compounds, PFOA (Perfluorooctanoic acid) and PFOS (Perfluorooctanesulfonic acid) being the most studied, can cross the blood-brain barrier; a highly selective, protective, and semi-permeable membrane that acts as a filter between the brain’s blood vessels and the brain tissue. Once in the brain, PFAS compounds have been implicated in disrupting lipid metabolism, altering neurotransmitter systems, and, crucially, inducing mitochondrial dysfunction and oxidative stress in neuronal cells.
Part III: The Evidence on the Ground
For those who remember their biology class in school, mitochondria are the powerhouses of the cell. If they are damaged or dysfunctional, the cell starves for energy. Motor neurons are huge, complex cells with long axons. Axons are long, slender, cable-like projections of neurons that transmit electrical impulses away from the cell body to other neurons, muscles, or glands, and they are extremely energy-demanding. They are, essentially, highly vulnerable to metabolic stress. If PFAS are causing mitochondrial dysfunction and oxidative stress in the motor neurons, that fits perfectly with the leading theories about how ALS begins at the cellular level. It’s like throwing sand in the engine of a very delicate and high-performance machine.
Second, the geographical and occupational clusters of ALS have been a major pointer. One of the most compelling pieces of evidence comes from the area surrounding the former Naval Air Warfare Center (NAWC) in Warminster, Pennsylvania, and the former Naval Air Station Joint Reserve Base (NASJRB) in Willow Grove, Pennsylvania.
These former military bases, like many others across the United States and even the world, were heavy users of Aqueous Film-Forming Foam or AFFF which contains high concentrations of PFAS. For decades, fire training exercises involving AFFF were common, and the foam often seeped into the groundwater. In the communities surrounding these bases, residents were exposed to high levels of PFAS in their drinking water.
In the early 2010s, researchers and advocates began to notice an alarming cluster of ALS cases on certain military bases and within nearby communities. The findings were stark: veterans with potential PFAS exposure from the bases showed a significantly elevated risk of developing ALS compared to the general veteran population. The studies provided a powerful, real-world indication that this was a path worth exploring.
Think about that for a moment. You have a known environmental release of a powerful, persistent neurotoxin right in the middle of a cluster of a rare, lethal neurological disease. It’s the kind of circumstantial evidence that screams for further investigation.
Beyond the military base clusters, other studies have attempted to find a biological signature. Researchers have measured PFAS levels in the blood serum of people with ALS and compared them to levels in healthy control groups. The results, while not universally conclusive, have been highly suggestive. Some studies have found that individuals with ALS tend to have higher concentrations of specific PFAS compounds, particularly PFOS, in their blood compared to controls. Moreover, some research has suggested that the higher the levels of certain PFAS, the younger the age of ALS onset. This implies a dose-response relationship, which is a key piece of the epidemiological puzzle.
Part IV: The Role of Genetics and Vulnerability
Let’s dig into the details of the mechanism a bit more, keeping a casual tone. Imagine the motor neuron as a house. It needs electricity (energy from mitochondria) to power its functions, and it needs a good security system (the blood-brain barrier and antioxidants) to keep out toxins.
PFAS seems to attack both the power supply and the security system.
When PFAS enters the motor neuron, it can disrupt the function of the mitochondria, decreasing the cell’s ability to generate the massive amount of Adenosine triphosphate, or ATP, or energy, it requires. ATP is the primary energy currency of all living cells, fueling processes like muscle contraction, nerve impulses, and chemical synthesis. When disruption occurs, this leads to energy deficiency, putting the already-stressed motor neuron under immense strain.
At the same time, PFAS exposure is linked to increased oxidative stress. Think of oxidative stress as rust, it’s damage caused by unstable molecules called free radicals; unstable, highly reactive atoms or molecules with an unpaired electron. When the motor neuron is overwhelmed by oxidative stress, its internal components, including DNA and proteins, are damaged. The cell struggles to repair itself, inflammation increases, and eventually, this relentless damage pushes the neuron past a point of no return, leading to programmed cell death, or apoptosis; the body’s normal, programmed process of “cellular suicide” used to eliminate damaged, unwanted, or unnecessary cells without causing inflammation. This is the very essence of ALS pathogenesis. PFAS itself isn’t causing a sudden, acute poisoning; it’s providing a chronic, low-level irritant that pushes genetically vulnerable or environmentally stressed motor neurons over the edge.
Another area of emerging research involves the potential for PFAS to disrupt lipid metabolism; the body’s process of breaking down dietary fats (triglycerides) for energy, storing excess fat for later use, and creating structural lipids for cell membranes. Neurons, and the myelin sheath, a protective, fatty, and protein-rich substance that wraps around nerve fibers (axons) in both the central and peripheral nervous systems, are rich in lipids (fats). PFAS are lipophilic, they love fat. They can accumulate in these fatty tissues and interfere with the normal movement and processing of lipids, which are essential for neuronal structure and signaling. Messing with the building blocks and insulation of a nerve cell is a sure-fire way to impair its function.
And what about the interaction with genetics? Only 10% of ALS cases are purely genetic. For the 90% of sporadic cases, the current working model is that the disease arises from a complex interaction between a person’s genetic predisposition (maybe they have a slightly less efficient system for clearing free radicals) and an environmental “hit” (like chronic PFAS exposure). PFAS might be the gun, but a subtle genetic vulnerability might be the trigger pulled only under chronic duress. This is why not everyone exposed to high levels of PFAS develops ALS, but the overall population risk may be significantly elevated.
This concept of gene-environment interaction is crucial. For instance, a common genetic mutation found in some ALS patients is in the C9orf72 gene. This gene provides instructions for making a protein that supports nerve cell health, particularly in the brain and spinal cord. People with a C9orf72 gene mutation may be inherently more susceptible to neuronal damage from environmental toxins. For someone carrying this kind of genetic vulnerability, exposure to PFAS might act as a potent, persistent catalyst for the disease process that wouldn’t happen in a genetically resistant individual.
Confirmation of a C9orf72 mutation requires a targeted genetic blood test, typically ordered by a physician or a genetic counselor, and is often prompted by a family history of ALS or frontotemporal dementia (FTD). However, as previously discussed, 90% of ALS cases are sporadic, meaning they manifest in individuals with no known family history of the disease. Consequently, as a non-scientist or health-care professional, yet one who faces an elevated risk of developing ALS due to personal PFAS exposure, I recommended that individuals who are or were employed in professions involving a high risk of PFAS exposure consult with their healthcare provider regarding the associated ALS risks. Furthermore, if feasible, they should inquire about undergoing a C9orf72 test. The cost of genome sequencing tests is variable, and individuals should consult their health-care provider regarding potential insurance coverage. It is essential to explain the rationale for this inquiry and to inform the provider of any known exposure, as providing supporting evidence will strengthen the justification for performing the test.
The research is, admittedly, still in its early stages. When discussing this connection, it’s vital to use careful language. We are talking about an association and a potential link, not a proven cause. Establishing causation in human neurological diseases is notoriously difficult. It takes large, long-term, meticulously controlled epidemiological studies. Researchers can’t ethically run an experiment where they give one group of people high levels of PFAS and see who gets ALS. They have to rely on retrospective studies, animal models, and cell culture work.
However, the weight of the evidence is growing. We have:
- Plausibility: PFAS are neurotoxic in laboratory models and their mechanism of action aligns with known ALS pathology (oxidative stress, mitochondrial dysfunction).
- Clustering: Specific, high-exposure communities (like those near military bases) show elevated rates of ALS.
- Biomarker Data: Some studies show higher PFAS levels in the blood of ALS patients compared to controls, sometimes correlating with a younger age of onset.
Part V: The Path Forward
So, where does the investigation stand right now, and what are the next steps?
Researchers are focusing on two main areas: large-scale epidemiology and targeted molecular studies.
On the epidemiological front, scientists are trying to leverage existing large cohort studies, like those involving veterans or residents of heavily contaminated areas, to find more robust, statistically significant correlations. They are trying to look beyond just PFOA and PFOS, the two most studied compounds, to the hundreds of other PFAS compounds that are also in use and circulation. It’s a huge undertaking because tracking environmental exposure that occurred decades ago is immensely difficult.
On the molecular front, laboratory scientists are using advanced techniques to culture human motor neurons from stem cells. They can then expose these “motor neurons in a dish” to various concentrations of PFAS to directly observe the cellular damage, measure changes in mitochondrial function, and track gene expression. This allows for a much more controlled, causal look at how PFAS directly harms the cells targeted by ALS.
In parallel, there’s a massive regulatory and environmental cleanup effort underway. The recognition of PFAS as a major public health crisis is leading to stricter regulations on their manufacturing and disposal, and a monumental effort is being launched to clean up contaminated sites, especially groundwater near military installations.
And this, frankly, is where the story gets deeply personal and moves into the realm of public health advocacy. For the individuals and families affected by ALS in these contamination hotspots, the scientific potential is already a lived reality. They are fighting for acknowledgment, for cleanup, and for the resources to study this potential link more aggressively. This is not just an academic debate; it’s a matter of justice and accountability.
The casual observer might ask, “If the link is only potential, why spend time talking about it?” The reason is simple: precautionary principle. When dealing with a pervasive contaminant that is known to accumulate in the body and a lethal, incurable disease, the mere potential for a link demands significant attention and action. It changes how we view exposure risks and how urgently we need to clean up the environment.
Ultimately, the story of PFAS and ALS is a microcosm of modern environmental health challenges. It highlights how synthetic chemicals, designed to make our lives easier and our products more durable, can have unforeseen and devastating biological consequences when released into the environment without adequate testing or regulation. It underscores the concept of the exposome, the totality of all environmental exposures an individual experiences over a lifetime. In the case of ALS, PFAS may just be one, albeit significant, piece of a larger toxic puzzle.
So, the takeaway to this article is one of vigilance and momentum. The scientific community is closing in on the answer. The evidence is mounting. We have biological plausibility, spatial clusters, and initial biomarker data all pointing toward a concerning association. This is a topic that requires continued attention, especially within the military and fire service communities, continued research funding, and, most importantly, continued pressure to mitigate exposure to these enduring, forever chemicals that may be contributing to one of the most heartbreaking neurological diseases known to humanity.